Literature DB >> 27407584

Aesthesioneuroblastoma of Nose.

S C Gupta1, A K Das2, M D Venkatesh3, R C Kashyap4, S Bhattacharya5.   

Abstract

Keywords:  Aesthesioneuroblastoma; Nasal tumours; Olfactory neuroblastoma

Year:  2011        PMID: 27407584      PMCID: PMC4923449          DOI: 10.1016/S0377-1237(04)80166-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


× No keyword cloud information.
  8 in total

1.  Olfactory neuroblastoma. A clinical analysis of 17 cases.

Authors:  S Kadish; M Goodman; C C Wang
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

2.  Esthesioneuroblastoma: the University of Virginia experience 1960-1985.

Authors:  P A Levine; W C McLean; R W Cantrell
Journal:  Laryngoscope       Date:  1986-07       Impact factor: 3.325

3.  Olfactory esthesioneuroma: a report of 40 cases.

Authors:  G Schwaab; C Micheau; C Le Guillou; L Pacheco; P Marandas; C Domenge; J M Richard; P Wibault
Journal:  Laryngoscope       Date:  1988-08       Impact factor: 3.325

Review 4.  Treatment of olfactory neuroblastoma. A report of 11 cases.

Authors:  A P Jekunen; K J Kairemo; H P Lehtonen; M J Kajanti
Journal:  Am J Clin Oncol       Date:  1996-08       Impact factor: 2.339

Review 5.  Cushing's syndrome secondary to olfactory neuroblastoma.

Authors:  M A Arnesen; B W Scheithauer; S Freeman
Journal:  Ultrastruct Pathol       Date:  1994 Jan-Apr       Impact factor: 1.094

6.  Olfactory neuroblastoma: report of a case associated with inappropriate antidiuretic hormone secretion.

Authors:  M al Ahwal; N Jha; J M Nabholtz; J Hugh; I Birchall; G K Nguyen
Journal:  J Otolaryngol       Date:  1994-12

7.  Olfactory neuroblastoma. Biologic and clinical behavior.

Authors:  K D Olsen; L W DeSanto
Journal:  Arch Otolaryngol       Date:  1983-12

8.  Olfactory neuroblastoma. A clinicopathologic study of 21 cases.

Authors:  S E Mills; H F Frierson
Journal:  Am J Surg Pathol       Date:  1985-05       Impact factor: 6.394

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.